8:30-8:45am (Coffee & Networking) 8:45-9:15am (Presentation) 9:15 – 9:45am (Networking) | Reviewing the Latest Product Development Trends in the Current Market Description M&A plays a pivotal role in pharma growth as it enables companies to streamline their operations and strategies while reducing overhead costs, which can contribute to profit growth. To understand more, join our informative session, where our market experts will highlight and discuss the latest trends in the market and the expectations for the market: Discussion Points: - Reviewing M&A trends in the North American Pharma Market
- Optimization of API process and selection of primary and secondary suppliers
- Drug development considerations for product development understanding scale, formulations for large volume
- Analytical Method optimization
| Sponsor: Design Space InPharmatics (DSI), LLC, a ProductLife Group (PLG) Company James Mencel, Ph.D., Head of Drug Substance Services, Design Space InPharmatics (DSI), LLC, a ProductLife Group (PLG) Company p Kyriakos Michailaros, Head of Drug Product Services, Design Space InPharmatics (DSI), LLC, a ProductLife Group (PLG) Company Colman Byrne, Head of Analytical Services, Design Space InPharmatics (DSI), LLC, a ProductLife Group (PLG) Company Asif Rahman, Business Development Director, Design Space InPharmatics (DSI), LLC, a ProductLife Group (PLG) Company |